Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Archives of Virology
|
January 1, 1981
In vitro and in vivo inhibition of myxoma virus by treatment with phosphonoacetic acid
J M Goodrich, K W Lee, H C Hinze
Archives of Virology
|
January 1, 1980
In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate
J M Goodrich, K W Lee, H C Hinze
Journal of Neural Transmission. Supplementum
|
January 1, 1990
A double-blind, placebo-controlled study of the tolerability and effects on platelet MAO-B activity of single oral doses of MDL 72.974A in normal volunteers
C Hinze, D Harland, M Zreika, et al.
Progress in Brain Research
|
January 1, 1995
Selectivity of MDL 72,974A for MAO-B inhibition based on substrate and metabolite concentrations in plasma
N D Huebert, V Schwach, C Hinze, et al.
Arzneimittel-Forschung
|
December 1, 1991
Effects of a standardized meal on the pharmacokinetics of the new cardiotonic agent piroximone
K D Haegele, C Hinze, A M Joder-Ohlenbusch, et al.
Journal of Virology
|
October 1, 1985
Herpesvirus sylvilagus infects both B and T lymphocytes in vivo
W J Kramp, P Medveczky, C Mulder, et al.
Zeitschrift Fur Rheumatologie
|
April 22, 2021
[Cushing's syndrome with subsequent tertiary adrenocortical insufficiency after simultaneous multiple intra-articular local glucocorticoid treatment : Keep an eye on hormone deficiency conditions requiring treatment after multiple administrations of local steroids]
A Schramm, D Windschall, C Hinze, et al.
Analytical Biochemistry
|
August 15, 1994
The measurement of beta-phenylethylamine in human plasma and rat brain
N D Huebert, V Schuurmans Schwach, G Richter, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1994
Kinetics and metabolism of p-tyramine during monoamine oxidase inhibition by mofegiline
N D Huebert, B D Dulery, J Schoun, et al.
The Journal of Antibiotics
|
March 1, 2000
Biomolecular-chemical screening: a novel screening approach for the discovery of biologically active secondary metabolites. III. New DNA-binding metabolites
C Maul, I Sattler, M Zerlin, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Archives of Virology
|
January 1, 1981
In vitro and in vivo inhibition of myxoma virus by treatment with phosphonoacetic acid
J M Goodrich, K W Lee, H C Hinze
Archives of Virology
|
January 1, 1980
In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate
J M Goodrich, K W Lee, H C Hinze
Journal of Neural Transmission. Supplementum
|
January 1, 1990
A double-blind, placebo-controlled study of the tolerability and effects on platelet MAO-B activity of single oral doses of MDL 72.974A in normal volunteers
C Hinze, D Harland, M Zreika, et al.
Progress in Brain Research
|
January 1, 1995
Selectivity of MDL 72,974A for MAO-B inhibition based on substrate and metabolite concentrations in plasma
N D Huebert, V Schwach, C Hinze, et al.
Arzneimittel-Forschung
|
December 1, 1991
Effects of a standardized meal on the pharmacokinetics of the new cardiotonic agent piroximone
K D Haegele, C Hinze, A M Joder-Ohlenbusch, et al.
Journal of Virology
|
October 1, 1985
Herpesvirus sylvilagus infects both B and T lymphocytes in vivo
W J Kramp, P Medveczky, C Mulder, et al.
Zeitschrift Fur Rheumatologie
|
April 22, 2021
[Cushing's syndrome with subsequent tertiary adrenocortical insufficiency after simultaneous multiple intra-articular local glucocorticoid treatment : Keep an eye on hormone deficiency conditions requiring treatment after multiple administrations of local steroids]
A Schramm, D Windschall, C Hinze, et al.
Analytical Biochemistry
|
August 15, 1994
The measurement of beta-phenylethylamine in human plasma and rat brain
N D Huebert, V Schuurmans Schwach, G Richter, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1994
Kinetics and metabolism of p-tyramine during monoamine oxidase inhibition by mofegiline
N D Huebert, B D Dulery, J Schoun, et al.
The Journal of Antibiotics
|
March 1, 2000
Biomolecular-chemical screening: a novel screening approach for the discovery of biologically active secondary metabolites. III. New DNA-binding metabolites
C Maul, I Sattler, M Zerlin, et al.
Page
of 3